ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
BCL2L10 | BCL2-like 10 (apoptosis facilitator) | Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD1A | CD1a molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDH3 | Cadherin 3, type 1, P-cadherin (placental) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLCA2 | Chloride channel accessory 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CXorf28 | Chromosome X open reading frame 28 | | | | | | Tissue enhanced |
DLK2 | Delta-like 2 homolog (Drosophila) | Predicted membrane proteins
| | | | | Tissue enhanced |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | | | | Tissue enhanced |
EPHB3 | EPH receptor B3 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
EPS8L1 | EPS8-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM83B | Family with sequence similarity 83, member B | | | | | | Tissue enhanced |
FAM83G | Family with sequence similarity 83, member G | | | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GRHL1 | Grainyhead-like 1 (Drosophila) | Transcription factors
| | | | | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
IVL | Involucrin | Plasma proteins
| | | | | Tissue enhanced |
JAG2 | Jagged 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
LRP4 | Low density lipoprotein receptor-related protein 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MEGF6 | Multiple EGF-like-domains 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
OTX1 | Orthodenticle homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
POSTN | Periostin, osteoblast specific factor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PPFIA3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | | | | | | Tissue enhanced |
PPP1R13L | Protein phosphatase 1, regulatory subunit 13 like | Transcription factors
| | | | | Tissue enhanced |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
PROM2 | Prominin 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
RNASE7 | Ribonuclease, RNase A family, 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
SCEL | Sciellin | Plasma proteins
| | | | | Tissue enhanced |
SPTBN2 | Spectrin, beta, non-erythrocytic 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
TP63 | Tumor protein p63 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
USH1G | Usher syndrome 1G (autosomal recessive) | Disease related genes
| | | | | Tissue enhanced |
WNT7B | Wingless-type MMTV integration site family, member 7B | Predicted secreted proteins
| | | | | Tissue enhanced |